Jump to main content
eTG Complete
Index
Search
Home
Rheumatology
Juvenile idiopathic arthritis
Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
Rheumatology
Assessment and initial management of musculoskeletal symptoms
Practical information on drugs used for musculoskeletal and rheumatological conditions
Adult-onset Still disease
Antiphospholipid syndrome
Autoinflammatory periodic fever syndromes
Back pain
Behçet syndrome
Crystal diseases including gout
Fibromyalgia
Idiopathic inflammatory myopathies
Immunoglobulin G
4
-related disease
Inflammatory connective tissue diseases
Juvenile idiopathic arthritis
Juvenile idiopathic arthritis
Oligoarticular juvenile idiopathic arthritis
Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis
Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
Introduction to rheumatoid factor-positive polyarticular JIA
Management for rheumatoid factor-positive polyarticular JIA
Nonpharmacological management for rheumatoid factor-positive polyarticular JIA
Pharmacological therapy for initial symptoms of rheumatoid factor-positive polyarticular JIA
Conventional synthetic disease-modifying antirheumatic drugs for rheumatoid factor-positive polyarticular JIA
Biological disease-modifying antirheumatic drugs for rheumatoid factor-positive polyarticular JIA
References
Systemic juvenile idiopathic arthritis
Enthesitis-related arthritis
Psoriatic juvenile idiopathic arthritis
JIA-associated uveitis
Overview of limb conditions
Upper limb conditions
Lower limb conditions
Neck pain
Osteoarthritis
Musculoskeletal conditions in children and adolescents
Polymyalgia rheumatica
Pregnancy-related low back pain and pelvic pain
Raynaud phenomenon
Rheumatoid arthritis
Spondyloarthritis
Systemic vasculitides
Transition of adolescents to adult rheumatology management
Viral arthritis
Rheumatoid factor-positive polyarticular juvenile idiopathic arthritis
Published
December 2024
Introduction to rheumatoid factor-positive polyarticular JIA
Management for rheumatoid factor-positive polyarticular JIA
Nonpharmacological management for rheumatoid factor-positive polyarticular JIA
Pharmacological therapy for initial symptoms of rheumatoid factor-positive polyarticular JIA
Conventional synthetic disease-modifying antirheumatic drugs for rheumatoid factor-positive polyarticular JIA
Biological disease-modifying antirheumatic drugs for rheumatoid factor-positive polyarticular JIA
